Table 2. RoB 2 [30]: A revised Cochrane risk-of-bias tool for randomized trials. This table demonstrates the risk of bias across included RCTs.
Study | Domain 1 | Domain 2 | Domain 3 | Domain 4 | Domain 5 | Overall risk of bias |
Webster et al. [31] | High | Low | Low | Low | Low | High |
Tack et al. [32] | Low | Low | Low | Low | Low | Low |
Webster et al. [33] | Low | Low | Low | Low | Low | Low |
Coyne et al. [34] | Low | Low | Low | Low | Low | Low |
Jansen et al. [35] | Low | Low | Low | Low | Low | Low |
Webster and Israel [36] | Low | Low | Low | Low | Low | Low |
Portenoy et al. [37] | High | Low | Low | Low | Low | High |
Thomas et al. [38] | Low | Low | Low | Low | Low | Low |
Bull et al. [39] | Low | Low | Low | Low | Low | Low |
Iyer et al. [40] | Low | Low | Low | Low | Low | Low |
Michna et al. [41] | Low | Low | Low | Low | Low | Low |
Rauck et al. [42] | Low | Low | Low | Low | Low | Low |
Webster et al. [43] | High | Low | Low | Low | Low | High |
Rauck et al. [44] | Low | Low | Low | Low | Low | Low |
Yuan et al. [45] | Low | Low | Low | Low | Low | Low |
Chamberlain et al. [46] | Low | Low | Low | Low | Low | Low |
Lipman et al. [47] | High | Low | Low | Low | Low | High |
Nalamachu et al. [48] | Low | Low | Low | Low | Low | Low |
Yuan et al. [49] | Low | Low | Low | Low | Low | Low |
Wild et al. [50] | Low | Low | Low | Low | Low | Low |
Katakami et al. [51] | Low | Low | Low | Low | Low | Low |
Katakami et al. [52] | Low | Low | Low | Low | Low | Low |
Hale et al. [53] | Low | Low | Low | Low | Low | Low |
Webster et al. [54] | Low | Low | Low | Low | Low | Low |
Webster et al. [55] | Low | Low | Low | Low | Low | Low |
Saito et al. [56] | High | Low | Low | Low | Low | High |